Showing results (601-610 of 661) with videos related to
Sort By:
Pageof 67
Nature Cancer|May 22, 2023
The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLCAaron Javitt, Merav D Shmueli, Matthias P Kramer, et al.Nature Cancer|March 26, 2021
Combined inhibition of Aurora-A and ATR kinase results in regression of MYCN-amplified neuroblastomaIsabelle Roeschert, Evon Poon, Anton G Henssen, et al.Nature Cancer|April 10, 2023
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trialLeonie Voorwerk, Olga I Isaeva, Hugo M Horlings, et al.Nature Cancer|August 18, 2020
The T cell differentiation landscape is shaped by tumour mutations in lung cancerEhsan Ghorani, James L Reading, Jake Y Henry, et al.Nature Cancer|April 9, 2021
Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapyRobert M Samstein, Chirag Krishna, Xiaoxiao Ma, et al.Nature Cancer|April 26, 2021
Emerging strategies for treating metastasisMark Esposito, Shridar Ganesan, Yibin KangNature Cancer|April 19, 2021
The Metabolic Landscape of RAS-Driven Cancers from biology to therapySuman Mukhopadhyay, Matthew G Vander Heiden, Frank McCormickNature Cancer|August 18, 2025
Prospects for ferroptosis therapies in cancerJessalyn M Ubellacker, Scott J DixonNature Cancer|August 8, 2025
SWIFT-seq enables comprehensive single-cell transcriptomic profiling of circulating tumor cells in multiple myeloma and its precursorsElizabeth D Lightbody, Romanos Sklavenitis-Pistofidis, Ting Wu, et al.Nature Cancer|October 23, 2025
Engineering T cells with a membrane-tethered version of SLP-76 overcomes antigen-low resistance to CAR T cell therapyMaria Caterina Rotiroti, Aidan M Tousley, Hoyin Chu, et al.Pageof 67